NASDAQ$OMER
Omeros Corp · Q1 2021 earnings
Q1 2021 earnings · · Investor relations
Briefing
Omeros reported a net loss for Q1 2021, but saw increased OMIDRIA revenues.
Omeros Corporation reported first quarter 2021 financial results, with OMIDRIA revenues at $21.1 million. The company's net loss was $35.1 million, or $0.57 per share. As of March 31, 2021, Omeros had $100.5 million in cash, cash equivalents and short-term investments.
- OMIDRIA revenues for Q1 2021 were $21.1 million.
- Net loss in Q1 2021 was $35.1 million, or $0.57 per share.
- Omeros had cash, cash equivalents and short-term investments of $100.5 million as of March 31, 2021.
- Dosing of patients with narsoplimab in the I-SPY COVID-19 platform trial began in March 2021.
Headline financials
Revenue & EPS history
Omeros · Revenue · Quarterly
$21.1M
Revenue by segment
Omeros · $31.9M total across 1 segment · Q4 2021
- OMIDRIA royalties$31.9M—100.0%
Forward guidance
Omeros is progressing toward the anticipated launch of narsoplimab for TA-TMA and building momentum with OMIDRIA following CMS' confirmation of separate payment for OMIDRIA in the ASC setting.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q1 2021
+2.4%
Avg return
Earnings day
+4.6%
Avg return
5 days after
+7.1%
Avg return
30 days after
43%
28 / 65 earnings
Positive
+64.2%
Q4 2019
Best reaction
-21.2%
Q1 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2025 | +7.5% | -7.1% | — | |
| Q1 2026 | -2.5% | -20.8% | -40.9% | |
| Q3 2025 | +26.3% | +30.9% | +61.6% | |
| Q2 2025 | +7.0% | +1.7% | +0.7% | |
| Q1 2025 | -18.7% | -21.3% | -13.9% | |
| Q4 2024 | -3.8% | -14.1% | -14.6% | |
| Q3 2024 | +63.1% | +39.0% | +79.1% | |
| Q2 2024 | -10.5% | -2.1% | -16.7% | |
| Q1 2024 | -21.2% | -21.4% | -3.3% | |
| Q4 2023 | -11.6% | -0.6% | -1.4% | |
| Q3 2023 | -3.8% | +14.6% | +97.7% | |
| Q2 2023 | -1.2% | -6.1% | -20.7% | |
| Q1 2023 | +21.2% | +14.2% | +51.4% | |
| Q4 2022 | +15.6% | +8.6% | +72.1% | |
| Q3 2022 | -16.9% | -10.9% | -35.6% | |
| Q2 2022 | +10.5% | +5.6% | -19.4% | |
| Q1 2022 | -5.4% | +15.9% | -22.5% | |
| Q4 2021 | -5.1% | -11.2% | -16.5% | |
| Q3 2021 | +7.6% | +10.1% | +6.3% | |
| Q2 2021 | +1.5% | +4.4% | +5.3% | |
| Q1 2021 | +3.8% | +2.5% | -9.6% | |
| Q4 2020 | +1.2% | -7.3% | -10.7% | |
| Q3 2020 | +6.1% | +11.3% | +37.0% | |
| Q2 2020 | +12.5% | -4.0% | -22.2% | |
| Q1 2020 | -6.2% | -12.0% | -2.2% | |
| Q4 2019 | +64.2% | +51.8% | +8.7% | |
| Q3 2019 | +2.2% | -3.9% | -3.9% | |
| Q2 2019 | +14.7% | +20.6% | +14.4% | |
| Q1 2019 | +5.1% | +0.9% | -8.3% | |
| Q4 2018 | +12.5% | +9.2% | +20.5% | |
| Q3 2018 | -20.3% | -22.2% | -14.2% | |
| Q2 2018 | -18.0% | -4.7% | +16.9% | |
| Q1 2018 | +18.0% | +45.0% | +8.7% | |
| Q4 2017 | -0.9% | -0.1% | +10.6% | |
| Q3 2017 | +27.5% | +33.1% | +37.5% | |
| Q2 2017 | +12.4% | +5.9% | -6.8% | |
| Q1 2017 | -7.7% | -6.4% | -4.7% | |
| Q4 2016 | -7.9% | -2.9% | +34.7% | |
| Q3 2016 | +28.7% | +45.8% | +9.4% | |
| Q2 2016 | +3.0% | -7.9% | -8.9% | |
| Q1 2016 | -15.0% | — | — | |
| Q4 2015 | +24.7% | — | — | |
| Q3 2015 | -1.3% | — | — | |
| Q2 2015 | -3.1% | — | — | |
| Q1 2015 | +4.8% | — | — | |
| Q4 2014 | -6.2% | — | — | |
| Q3 2014 | +9.7% | — | — | |
| Q2 2014 | -5.7% | — | — | |
| Q1 2014 | -6.9% | — | — | |
| Q4 2013 | -11.7% | — | — | |
| Q3 2013 | -5.6% | — | — | |
| Q2 2013 | -7.2% | — | — | |
| Q1 2013 | +17.5% | — | — | |
| Q4 2012 | -3.7% | — | — | |
| Q3 2012 | -17.1% | — | — | |
| Q2 2012 | -2.2% | — | — | |
| Q1 2012 | -0.6% | — | — | |
| Q4 2011 | -3.5% | — | — | |
| Q3 2011 | -2.0% | — | — | |
| Q2 2011 | +3.0% | — | — | |
| Q1 2011 | -0.8% | — | — | |
| Q4 2010 | -3.8% | — | — | |
| Q3 2010 | -3.2% | — | — | |
| Q2 2010 | -12.3% | — | — | |
| Q1 2010 | -3.2% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro